Rani Therapeutics Holdings, Inc. (RANI)
0.6406
-0.04
(-5.79%)
USD |
NASDAQ |
Oct 16, 16:00
0.6392
0.00 (0.00%)
After-Hours: 20:00
Rani Therapeutics Holdings Total Assets (Quarterly) : 60.84M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.84M |
| March 31, 2026 | 51.88M |
| December 31, 2025 | 58.62M |
| September 30, 2025 | 10.14M |
| June 30, 2025 | 16.90M |
| March 31, 2025 | 24.12M |
| December 31, 2024 | 36.63M |
| September 30, 2024 | 43.54M |
| June 30, 2024 | 43.73M |
| March 31, 2024 | 53.51M |
| December 31, 2023 | 57.92M |
| Date | Value |
|---|---|
| September 30, 2023 | 70.44M |
| June 30, 2023 | 83.51M |
| March 31, 2023 | 96.45M |
| December 31, 2022 | 108.03M |
| September 30, 2022 | 108.20M |
| June 30, 2022 | 104.34M |
| March 31, 2022 | 115.31M |
| December 31, 2021 | 124.21M |
| September 30, 2021 | 136.96M |
| June 30, 2021 | 77.32M |
| March 31, 2021 | 82.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
| Definium Therapeutics, Inc. | 1.113B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.86M |
| Shareholders Equity (Quarterly) | 39.23M |
| Debt to Equity Ratio | 0.0905 |
| Current Ratio | 5.313 |
| Net Debt Paydown Yield | 5.17% |